Suven Life shares up 2.5% on patent for neurodegenerative drug

Shares of Suven Life Sciences today rose by 2.5 per cent as its drug used in the treatment of disorders associated with neurodegenerative diseases received a patent each by Europe and Macau.
The stock gained 2.54 per cent to settle at Rs 268.60 on BSE. During the day, it rose by 5 per cent to Rs 275.20.
At NSE, shares of the company climbed 2.59 per cent to end at Rs 268.80.
In terms of volume, 2.71 lakh shares of the company changed hands at BSE and over 11 lakh shares were traded at NSE during the day.
"The company has been granted one product patent from Europe and one product patent from Macau corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases", Suven Life said in a BSE filing.

The patents are valid through 2030 and 2029.